Actively Recruiting
Blood Markers of Early Pancreas Cancer
Led by University of Nebraska · Updated on 2026-02-02
1250
Participants Needed
1
Research Sites
518 weeks
Total Duration
On this page
Sponsors
U
University of Nebraska
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.
CONDITIONS
Official Title
Blood Markers of Early Pancreas Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 19 years or older
- Able to provide written, informed consent
- Able to attend in-person study visits in Omaha, NE twice a year for blood sample collection
- Meet criteria for at least one risk group: new onset type 2 diabetes diagnosed within past 3 years, high-risk pre-diabetes, pancreatic cystic neoplasm or chronic pancreatitis diagnosed by imaging or specialist, or inherited risk due to family history or specific genetic mutations
You will not qualify if you...
- Personal history of pancreatic ductal adenocarcinoma (PDAC)
- Currently receiving treatment for cancer (except long-term hormonal therapy)
- Pre-diabetes treated with metformin for 3 years or longer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Unversity of Nebraska Medical Center
Omaha, Nebraska, United States, 68198
Actively Recruiting
Research Team
S
Suzanne M Wessling, RN, BSN
CONTACT
K
Kelsey A Klute, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here